These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

311 related items for PubMed ID: 6898604

  • 41.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 42.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 43.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 44. A randomized comparison study of bretylium tosylate and lidocaine in resuscitation of patients from out-of-hospital ventricular fibrillation in a paramedic system.
    Olson DW, Thompson BM, Darin JC, Milbrath MH.
    Ann Emerg Med; 1984 Sep; 13(9 Pt 2):807-10. PubMed ID: 6383135
    [Abstract] [Full Text] [Related]

  • 45. Clinical pharmacokinetics of intravenous and oral bretylium tosylate in survivors of ventricular tachycardia or fibrillation: clinical application of a new assay for bretylium.
    Anderson JL, Patterson E, Wagner JG, Johnson TA, Lucchesi BR, Pitt B.
    J Cardiovasc Pharmacol; 1981 Sep; 3(3):485-99. PubMed ID: 6168830
    [Abstract] [Full Text] [Related]

  • 46. [Bretylium tosylate--a new antiarrhythmic agent with antifibrillatory effect].
    Dvorák K, Vavros B, Cerný J.
    Vnitr Lek; 1975 Mar; 21(3):278-84. PubMed ID: 47209
    [No Abstract] [Full Text] [Related]

  • 47. Prevention of ventricular fibrillation by bretylium in a conscious canine model of sudden coronary death.
    Holland K, Patterson E, Lucchesi BR.
    Am Heart J; 1983 May; 105(5):711-7. PubMed ID: 6846113
    [Abstract] [Full Text] [Related]

  • 48. Bretylium in severe ventricular arrhythmias associated with digitalis intoxication.
    Vincent JL, Dufaye P, Berre J, Kahn RJ.
    Am J Emerg Med; 1984 Nov; 2(6):504-6. PubMed ID: 6529463
    [Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52. Massive intravenous bolus bretylium tosylate.
    Bodnar T, Nowak R, Tomlanovich MC.
    Ann Emerg Med; 1980 Dec; 9(12):630-3. PubMed ID: 7447102
    [Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55. [Use of bretylium toxilate in the course of myocardial infarct complicated by ventricular arrhythmia].
    Brusoni B, Cadel A, De Vita C.
    Boll Soc Ital Cardiol; 1971 Dec; 16(5):211-20. PubMed ID: 4109908
    [No Abstract] [Full Text] [Related]

  • 56. Bretylium tosylate versus lidocaine in experimental cardiac arrest.
    Vachiery JL, Reuse C, Blecic S, Contempré B, Vincent JL.
    Am J Emerg Med; 1990 Nov; 8(6):492-5. PubMed ID: 2222590
    [Abstract] [Full Text] [Related]

  • 57. Pharmacologic reversal of hypotensive effect complicating antiarrhythmic therapy with bretylium.
    Woosley RL, Reele SB, Roden DM, Nies AS, Oates JA.
    Clin Pharmacol Ther; 1982 Sep; 32(3):313-21. PubMed ID: 7105622
    [No Abstract] [Full Text] [Related]

  • 58. Bretylium tosylate in prevention of cardiac dysrhythmias after myocardial infarction.
    Taylor SH, Saxton C, Davies PS, Stoker JB.
    Br Heart J; 1970 May; 32(3):326-9. PubMed ID: 4911756
    [Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 16.